Five Prime Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Five
Five Prime Therapeutics, Inc. had Lessee, Operating Lease, Liability, to be Paid, Year Five of $8.34 million as of 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive · last filed 2020-08-06
- 2020-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Five $8.34M.
- 2020-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $8.34M.
- 2019-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $8.34M.
- 2019-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Five $8.06M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Five |
|---|---|
| 2020-06-30 | $8.34M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $8.34M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $8.34M 10-K · filed 2020-02-27 |
| 2019-09-30 | $8.06M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $8.06M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $8.06M 10-Q · filed 2019-05-09 |